CHRONIC DEMYELINIZING POLYNEUROPATHY: ETIOPATHOGENETIC, CLINICAL ASPECTS, MODERN DIRECTIONS OF MEDICAL THERAPY
DOI:
https://doi.org/10.31618/nas.2413-5291.2021.1.67.423Keywords:
demyelinating polyneuropathy; off - lable therapy; rituximab; immunosuppressive therapyAbstract
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder of the peripheral nervous system. The article discusses the practical experience of using off label therapy with rituximab in the complex treatment of a patient with a progressive course of chronic inflammatory demyelinating polyneuropathy. Due to the ineffectiveness of standard therapy, the option of treatment with genetically engineered drugs (rituximab) was considered. The use of rituximab contributed to the achievement of positive dynamics and an improvement in the patient's quality of life.
References
Alekseenko Yu.V. Nevrologiya i nejrohirurgiya: posobie. – Vitebsk: VGMU, 2014. – 290 s.
Levin O.S. Polinevropatii: klinicheskoe rukovodstvo / O.S. Levin. - 3-e izd., ispr. i dop. - M. : MIA, 2016. - 480 s.
Popova T.E., Shnajder N.A., Petrova M.M. i dr. Epidemiologiya hronicheskoj vospalitelnoj demieliniziruyushej polinevropatii za rubezhom i v Rossii // Nervno-myshechnye bolezni. 2015. T. 5, № 2. S. 10-15.
Suponeva N.A. Klinicheskaya i diagnosticheskaya rol autoantitel k gangliozidam perifericheskih nervov: obzor literatury i sobstvennye dannye // Nervno-myshechnye bolezni. – 2013. – № 1. – S. 26 – 35.
Shnajder N.A., Popova T. E. Novyj podhod k nejrofiziologicheskoj diagnostike sensornogo varianta hronicheskoj vospalitelnoj demieliniziruyushej polinevropatii s ispolzovaniem sovremennyh medicinskih tehnologij// Mezhdunarodnyj zhurnal eksperimentalnogo obrazovaniya. – 2015. – № 10 (chast 1) – S. 76-87.
Medicinskij portal "MED-info" 2011— 2015 MED-INFO.RF: svidetelstvo o registracii NFS77-45549 ot 29 iyunya 2011 goda.
Lechenie ostroj i hronicheskoj vospalitelnoj demieliniziruyushej poliradikulonejropatii – rezhim dostupa k izd.: http://www.paininfo.ru/articles/rmj/856.html. 8. Nevrologiya. Nacionalnoe rukovodstvo. Kratkoe izdanie / pod red. E. I. Guseva, A. N. Konovalova, A. B. Geht. - M. : GEOTAR Media, 2018. - 688 s. - ISBN 978-5-9704-4405-4.
Bril V., Blanchette C. M., Noone J. M. et al. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy // J. Diabetes Complications. – 2016. – № 30 (7). – R. 1401-1407 – rezhim dostupa k izd.: http://dx.doi.org/10.1016/jdiacomp.2016.05.007.
Schneider-Hohendorf T., Schwab N., Uceyler N., et al. CD8+ T-cell immunity in chronic infl ammatory demyelinating polyradiculoneuropathy // Neurology. – 2012. – Vol. 78. – R. 402.
Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 86, 9 (2015):973-85.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
